These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1517684

  • 1. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.
    Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ.
    J Lab Clin Med; 1992 Sep; 120(3):380-6. PubMed ID: 1517684
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
    Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY, Appelman H.
    J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
    [Abstract] [Full Text] [Related]

  • 6. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
    Brewer GJ, Hill GM, Dick RD, Nostrant TT, Sams JS, Wells JJ, Prasad AS.
    J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
    [Abstract] [Full Text] [Related]

  • 7. Zinc therapy induction of intestinal metallothionein in Wilson's disease.
    Brewer GJ.
    Am J Gastroenterol; 1999 Feb; 94(2):301-2. PubMed ID: 10022620
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Copper in the feces--a marker for the effectiveness of zinc in the treatment of Wilson's disease].
    Dastych M.
    Z Gastroenterol; 1990 Aug; 28(8):389-91. PubMed ID: 2275259
    [Abstract] [Full Text] [Related]

  • 11. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K, Siegemund R, Lössner J, Kühn HJ.
    Radiobiol Radiother (Berl); 1988 Aug; 29(2):226-9. PubMed ID: 3399664
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA.
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration).
    Nartey NO, Frei JV, Cherian MG.
    Lab Invest; 1987 Oct; 57(4):397-401. PubMed ID: 3312808
    [Abstract] [Full Text] [Related]

  • 19. Zinc therapy in Wilson's disease: observations in five patients.
    Rossaro L, Sturniolo GC, Giacon G, Montino MC, Lecis PE, Schade RR, Corazza GR, Trevisan C, Naccarato R.
    Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model.
    Lee DY, Brewer GJ, Wang YX.
    J Lab Clin Med; 1989 Dec; 114(6):639-45. PubMed ID: 2592854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.